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Introduction: Mesenchymal stem cells (MSCs) have been reported to be a valu-
able cell source in regenerative medicine, and bone marrow represents a major
source of MSCs. Recently, it has been shown that MSC can be easily isolated
from human amnion, which is generally discarded after delivery, and a large
amount of cells can be obtained. We have previously reported that intravenous
administration of human amnion-derived MSCs (hAMSCs) provided signifi-
cant improvement in rats with colitis induced by dextran sulfate sodium or g-
irradiation. In addition, conditioned medium (CM) obtained from MSCs con-
tains a variety of humoral factors to improve damaged tissues. In this study, we
investigated the effects of hAMSCs and CM in rats with 2,4,6-trinitrobenzene
sulfonic acid (TNBS)-induced colitis.
Aims & Methods: hAMSCs were isolated and expanded by digestion with col-
lagenase, followed by culturing in uncoated plastic dishes. CM was collected by
culturing subconfluent hAMSCs with serum-free MEMa for 48 hrs. CM gel
was prepared by mixing CM with 2% carboxymethyl cellulose. On day 0,
200l of TNBS (15mg/rat) in 30% ethanol was intrarectally administered to
the ten-week-old male Sprague-Dawley (SD) rats. One-million hAMSCs were
intravenously administered 3 hrs after TNBS treatment, and rats were sacrificed
on day 7 for histological examination and quantitative PCR. In another experi-
ment, 400l of CM gel was intrarectally administered 3 hrs after TNBS treat-
ment, and day 1 and day 2.
Results: hAMSC transplantation and CM gel enema significantly improved the
endoscopical score, and tended to improve the histological score. Quantitative
PCR demonstrated that the expression levels of TNF-, CXCL1 and CCL2
tended to be decreased by hAMSC transplantation and CM gel enema.
Infiltrations ofCD68-positivemacrophages andmyeloperoxidase-positive neutro-
phils were significantly decreased by hAMSC transplantation and CM gel enema.
Conclusion: Transplantation of hAMSCs and CM gel enema provided signifi-
cant improvement in rats with colitis induced by TNBS. hAMSCs or CM from
hAMSCs may be new therapeutic strategies inflammatory bowel disease.
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Introduction: There is recent evidence of increased naı̈ve and central memory T
lymphocytes (TN and TCM) mucosal infiltration of the inflamed gut in
Inflammatory Bowel Disease (IBD), while TN and TCM cells were thought to
migrate exclusively to secondary lymphoid organs (SLOs). Ectopic formation
of tertiary lymphoid organs (TLOs) containing peripheral lymph node adressin
(PNAd)þ high endothelial venules (HEVs) might explain the homing of these
lymphocytes to the gut, as PNAd is the ligand of L-selectin which is expressed
on TN and TCM lymphocytes.
Aims &Methods: The aim of this study was to investigate the presence of PNAd
expressing HEVs and TLOs in the inflamed intestinal mucosa of newly diag-
nosed, untreated, IBD patients in relation to the presence of TN and TCM
lymphocytes. Thirty-nine newly diagnosed, untreated IBD patients and eight
healthy controls were prospectively included. Intestinal biopsy samples were
analysed by immunohistochemistry for blood vessels (CD31) and PNAd
expression (MECA-79), the density of MECA-79þ vessels was calculated and
the presence of lymphoid follicles was assessed. Different lymphocytes subsets




memory T cells (CD45RA-CD27-).
Results: A statistically significant higher number of extra-follicular PNAdþ
vessels were found in the inflamed colon of patients with ulcerative colitis
(median density of 3.05 PNAdþ vessels/mm2 (IQR 0–6.39)) and ileum of
patients with Crohn’s disease (median density of 1.40 PNAdþ vessels/mm2
(IQR 0–4.34)) compared with healthy controls (median density of colon: 0
PNADþ vessels/mm2 (IQR 0–0, p¼ 0.033) and ileum: 0 PNAdþ vessels/mm2
(IQR 0–0.50, p¼ 0.033)). The heterogeneity of extra-follicular PNAdþ vessels
in IBD patients allowed classification in two different groups: HEVhigh and
HEVlow. A high density of PNAdþ HEV-like vessels was associated with
increased numbers of TN and TCM in the inflamed gut mucosa (median 87%
(IQR 82–93%) of total T cell population), compared with the inflamed mucosa
of patients from the HEVlow group (58% (IQR 38–81%) p¼ 0.003). The
number of colonic follicles was higher in HEVhigh patients (median 0.54/mm2
(IQR 0.28–0.84)) when compared with HEVlow patients (median 0.25/mm2
(IQR 0.08–0.45) p¼ 0.031) and controls (0.31/mm2 (IQR 0.23–0.45) p¼ 0.043).
Conclusion: For the first time, evidence has been delivered of extra-follicularHEV-
like vessels and TLOs, strongly associated with TN and TCM cell mucosal infiltra-
tion, in a subgroup of newly diagnosed IBD patients. Different T cell migration
phenotypes based on TLO formation in the early phase of IBD might allow risk-
stratification of patients and enable more effective, individualized treatment.
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Introduction: Toll-like receptor 9 (TLR9) is expressed in intestinal epithelial cells,
which recognize microbiota developing different responses 1. Several studies
have shown that TLR9 seems to be involved in Inflammatory Bowel Diseases
(IBD) due to an inappropriate defensive response against microorganisms 2.
Moreover, intestinal serotonergic system is also altered in IBD, where extracel-
lular serotonin (5–HT) levels are increased 3. 5-HT bioavailability is mainly
regulated by the serotonin transporter (SERT), expressed in enterocytes 4.
Aims & Methods: The aim of the present study was to analyse whether TLR9
activation affects SERT expression and activity, and expression of other ele-
ments from the serotonergic system (TPH1, TPH2 and 5-HT receptors).
Human enterocyte-like Caco-2 cells, and ileum and colon from TLR9-/- mice
and Dextran Sulphate Sodium (DSS) mouse colitis model were used as experi-
mental models. mRNA expression was determined by RT-qPCR, and protein
expression by western blot.
Results: TLR9 activation in Caco-2 cells decreased SERT mRNA and protein
expression. TLR9 activation also reduced SERT activity by different intracel-
lular pathways, depending on activation period. Indeed, TLR9 long-time acti-
vation altered 5-HT uptake through ERK pathway, whereas short-time
activation modified SERT by p38/MAPK pathway. Moreover, 5-HT addition
to culture media increased TLR9 protein expression in the brush-border mem-
brane of Caco-2 cells. In TLR9-/- mice were observed different expression pat-
terns. SERT was not modified in ileum, but increased in colon. TPH1 was
increased in ileum, and TPH2, in colon. Regarding 5-HT receptors, 5HT2A,
5-HT2B, and 5-HT3 were increased in ileum; however, 5-HT1A, 5-HT2A and
5-HT4 were increased in colon. In both ileum and colon of DSS mice, TLR9
and 5-HT7 mRNA expression were increased, whereas SERT expression was
diminished.
Conclusion: Our results suggest that TLR9 modulates intestinal serotonergic
system. Indeed, TLR9 activation decreases SERT function and expression by
different pathways. In part, this is corroborated by the decreased expression of
SERT in colon of TLR9 knockout mice and altered 5-HT receptors expression.
Finally, SERT and TLR9 are inversely disturbed in DSS mice colitis model.
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López A and Yamamoto-Furusho JK. Transcript levels of Toll-Like
Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative
Colitis. BMC Gastroenterol 2011; 11: 138.
3. Shajib and MSKhan WI. The role of serotonin and its receptors in activa-
tion of immune responses and inflammation. Acta Physiol (Oxf) 2015;
213(3): 561–74.
4. Gershon. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract.
Curr Opin Endocrinol Diabetes Obes 2013; 20(1): 14–21MD.
A426 United European Gastroenterology Journal 3(5S)
